USPTO serial 77842866
BIOCENCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 13, 2011
- Examiner
- BROWNE, DAYNA
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with BIOCENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William J. Benman
William J. Benman Benman, Brown & Williams1999 Avenue of the Stars, Suite 1100LOS ANGELES, CA 90067UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preservatives for use in the production of a wide variety of chemicals, Preservatives for pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Bacillus anthracis, Anthrax, Bacillus cereus, B. cereus food poisoning, Clostridium botulinum, Botulism, Clostridium perfringens, Clostridialmyonecrosis (gas gangrene), Clostridium tetani, Tetanus (lockjaw), Corynebacteriuni diphtheria, Diphtheria, Escherichia coli, Diarrhea, Klebsiella pneumonia, Bronchopneumonia, Legionellapneumophila, Legionnaire's disease, Mycobacterium leprae, Leprosy, Mycobacteriumtuberculosis, Tuberculosis, Salmonella species, Salmonella, Salmonella typhi, Typhoid fever, Salmonella typhimurium, Salmonella gastroenteritis, Shigella dysenteriae, Bacillary dysentery, Shigella species, Shigellosis, Yersinia enterocolitica, Yersiniosis, gastroenteritis, Yersiniapestis, Plague, Yersinia pseudotuberculosis, Mesenteric lymphadenitis, Chlamydia, Chlamydiatrachomatis, Trachoma, urethritis, cervicitis, conjunctivitis, Bordetella pertussis, (whooping cough), Brucella species, Undulant fever, Hemophilus influenza, Meningitis, bacterial pneumonia, Hemophilus pertussis, (whooping cough), Neisseria gonorrhoeae, Gonorrhea, pelvicinflammatory disease, Neisseria meningitides, Meningitis, Staphylococcus aureus, Pneumonia, toxic shock syndrome, skin infections, meningitis, Streptococcus pneumonia, Pneumonia, ear infections, meningitis, Streptococcus pyogenes, Strep throat, rheumatic fever, Streptococcusspecies, Scarlet fever, puerperal fever, Listeria monocytogenes, Listeriosis, perinatal septicemia, meningitis, encephalitis, intrauterine infections, Mycoplasma pneumonia, Pneumonia, Rickettsia prowazekii, Epidemic typhus, Brill-Zinsser disease (spread by lice), Rickettsiarickettsii, Rocky Mountain spotted fever (spread by ticks), Rickettsia typhi, Endemic typhus (murine typhus, spread by rat fleas), Campylobacter fetus jejuni, Campylobacteriosis (bacterial diarrheal illness), Spirillum minor, Rat-bite fever, Spirochete Treponema pallidum, Syphilis, Aeromonas hydrophila, Gastroenteritis, septicemia, cellulitis, wound infections, urinary tractinfections, Plesiomonas shigelloides, Gastroenteritis, diarrhea, Vibrio cholerae 01, Epidemiccholera, Vibrio cholerae 01, Gastroenteritis, Vibrio parahemolyticus, V. parahemolyticus associated gastroenteritis, Vibrio vulnificus, Wound infections, gastroenteritis, primarysepticemia, Shigella flexneri, S. dysenteria, Vibrio cholera, Salmonella typhi, Salmonella, Enterotoxigenic Escherichia coli, Enterococcus faecalis, B. anthracis Pseudomonas aeruginosa, Mycobacterium chelonae, Candida albicans, Campylobacter, Mycobacterium tuberculosis, Diarrhoeal diseases, respiratory tract infections, meningitis, sexually transmitted infections, Streptococcus pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, multi-resistant salmonellae, Clostridium difficile and multi-resistant Mycobacterium, tuberculosis and emerging Infectious Diseases, Virucidal disease and conditions of Influenza, Bird HiNI HIIY, herpes simplex virus type 1 and type 2, AvianFlu, Foot and Mouth disease, Ebola virus, Pox virus, Smallpox virus, Talfan disease virus, Sindbis virus, Adenovirus (Common cold), Bunyavirus, Hantaan, La Crosse, Sin Nombre (Kidney failure), Encephalitis (brain infection), Lung syndrome, Calicivirus Norwalk Gastroenteritis (diarrhea, vomiting), Coronavirus (Corona Common cold), Filovirus Ebola, Marburg Hemorrhagic (fever), Hemorrhagic (fever), Flavivirus Hepatitis C (non-A, non-B): Yellow fever (Hepatitis), Hepatitis, hemorrhage, Hepadnavirus Hepatitis B virus (I-IBV), Hepatitis, liver carcinoma, Herpesvirus, Cytomegalovirus, Epstein-Barr virus (EBV), Herpes simplex type 1, Herpes simplex type 2, Human herpesvirus 8 (HHV8), Varicella-zoster, Birthdefects, Mononucleosis, nasopharyngeal carcinoma, Cold sores, Genital lesions, Kaposi'ssarcoma, Chicken pox, shingles, Orthomyxovirus, Influenza types A and B Flu, Papovavirus, Human papillomavirus (ITPV), Warts, cervical carcinoma, Picornavirus, Coxsackie virus, Echovirus, Hepatitis A, Poliovirus, Rhinovirus, Myocarditis (heart muscle infection), Meningitis, Infectious hepatitis, Poliomyelitis, Common cold, Paramyxovirus, Measles, Mumps, Parainfluenza, Measles, Mumps, ear infections, Parvovirus, B 19 Fifth disease, chronic anemia, Poxvirus Orthopoxvirus Smallpox (eradicated), Reovirus Rotavirus, Diarrhea, Retrovirus, Human immunodeficiency virus (HIV), Human T-cell leukemia virus, (HTLV-l), Acquiredimmunodeficiency syndrome (AIDS), Adult T-cell leukemia, lymphoma, neurologic disease, Rhabdovirus, Rabies, Togavirus, Eastern equine encephalomyelitis, Encephalitis, Rubella, and birth defects | ACTIVE | Jan 17, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 27, 2022 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jan 27, 2022 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jan 27, 2022 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jan 27, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 18, 2021 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 13, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 19, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 19, 2017 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 18, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 6, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 25, 2012 | PRAN | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED | — |
| Sep 6, 2012 | PAPER RECEIVED | — | |
| Dec 13, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 8, 2011 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED | — |
| Nov 7, 2011 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 3, 2011 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 2, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2011 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 24, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 21, 2011 | IUAF | USE AMENDMENT FILED | — |
| Oct 21, 2011 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 24, 2011 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 29, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 25, 2011 | MREI | NOTICE OF REINSTATEMENT MAILED | — |
| Feb 24, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 23, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 23, 2011 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 23, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 22, 2011 | RGIA | REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED | — |
| Feb 16, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 16, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2010 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 20, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 20, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jul 9, 2010 | PAPER RECEIVED | — | |
| Feb 24, 2010 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 24, 2010 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 8, 2010 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Oct 14, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2009 | NWAP | NEW APPLICATION ENTERED | — |